Vmn2r92 inhibitors refers to a specific class of chemical agents that interact with the Vmn2r92 receptor, which is part of a larger family of receptors known as Vomeronasal type 2 receptors (V2Rs). These receptors are typically involved in the detection of pheromones, chemical compounds that play a crucial role in the communication between animals of the same species. V2Rs, including Vmn2r92, are predominantly found in the vomeronasal organ (VNO) of animals, an olfactory structure that is responsible for the detection of pheromonal signals. The VNO is particularly well studied in rodents, where it is essential for a variety of social behaviors, but its presence and functionality in humans is a subject of ongoing research and debate.
Vmn2r92 inhibitors, by design, bind to the Vmn2r92 receptor, effectively blocking the receptor's natural function. When these inhibitors attach to the receptor, they prevent the binding of the receptor's natural ligands, which are typically specific pheromones. This interaction is highly specific due to the unique shape and chemical properties of both the receptor and the inhibitor, which must be complementary for effective binding. The development of these inhibitors requires a deep understanding of molecular biology and biochemistry to ensure specificity and efficacy in binding. The mechanism by which Vmn2r92 inhibitors exert their effects is through the disruption of the normal signaling pathways that would be activated upon the receptor's interaction with its ligand, thus impeding the subsequent biological response that would normally follow ligand-receptor binding. This intricate interaction is a testament to the complexity of chemical signaling and the nuanced control of biological processes at the molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a phosphatase inhibitor that can prevent dephosphorylation, a process involved in signaling pathways. By inhibiting dephosphorylation, Vmn2r92-mediated signaling could be indirectly inhibited. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which blocks the PI3K/Akt pathway. Since PI3K signaling is critical for various cellular processes, inhibition by LY294002 may downregulate pathways that are positively regulated by Vmn2r92. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. The p38 MAP kinase pathway is involved in inflammatory responses and cellular stress, inhibition of which could impair processes that Vmn2r92 may be implicated in. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which specifically blocks the MAPK/ERK pathway. This inhibition may reduce signaling that could potentially be enhanced by Vmn2r92 activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, which can suppress cell growth and proliferation signals that may indirectly involve Vmn2r92 signaling pathways. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an EGFR tyrosine kinase inhibitor, which could downregulate signaling pathways that, when active, might involve Vmn2r92 in processes such as cell proliferation and differentiation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor, which can lead to the accumulation of proteins that may regulate or be regulated by Vmn2r92, potentially disrupting its normal functional activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, which can alter gene expression patterns and potentially downregulate genes that are activated by Vmn2r92 signaling. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin is a selective inhibitor of N-WASP, which is involved in actin polymerization. By inhibiting this process, cell motility and structure, which could be influenced by Vmn2r92, can be indirectly affected. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor that blocks MEK activation, which may indirectly inhibit Vmn2r92 by reducing the MAPK/ERK signaling implicated in processes potentially regulated by Vmn2r92. | ||||||